Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Measles cases are spreading in the US this year, with over 1,000 infections reported in Pennsylvania

A measles outbreak in Pennsylvania has topped 1,000 cases, with neighboring New York declaring a disaster emergency and mobilizing measures to fight the spread.

The United States is experiencing its worst measles outbreak in two decades, with over 1,000 cases reported in Pennsylvania alone, according to state health officials. The Centers for Disease Control and Prevention (CDC) has recorded 3,869 cases nationwide this year. The current outbreak began in April west of Philadelphia, and nearly 200 people have been hospitalized, with five deaths reported. Most of the cases involve unvaccinated individuals.

In neighboring New York, Governor Kathy Hochul declared a month-long state disaster emergency to bolster efforts to combat measles. Over 100 cases have been reported in New York State this year, with 92 cases in under-immunized rural areas since July 15. The executive order suspends regulations on administering vaccines, allowing paramedics, midwives, and nurses to act accordingly.

Measles symptoms include high fever, cough, and rash, and it can lead to serious complications, particularly in young children. The highly contagious disease can be prevented with vaccines but has seen a rise in skepticism due to disinformation about vaccine safety. In 2000, the US eliminated domestic measles spread with high vaccination rates, but coverage has dipped below the necessary 95% threshold to prevent outbreaks.

US Health and Human Services Secretary Robert F. Kennedy, Jr., who has expressed vaccine skepticism, maintains that the measles vaccine is the best defense against the infection but has also advocated unproven alternative treatments.

Written by urgent.news from DW News's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

This story

This is one outlet's version. Read the fullest account.

Every outlet that reported this, and when →

Read the original at dw.com →

More in Health & Medicine

Celltrion Launches Omlyclo in U.S., Targeting Early Lead in Omalizumab Biosimilar Market

Celltrion has entered the U.S. market for omalizumab biosimilars with the launch of Omlyclo, aiming to replicate the early market penetration it achieved in Europe and establish the product as a key…

  • Celltrion launches Omlyclo, first omalizumab biosimilar in U.S.
  • Introduced on October 5, offering 15% lower cost than reference product
  • Recognized as preferred drug by major PBMs, securing U.S. formulary placement

More from Tuesday 6 October →